Cannon Global Investment Management »

Contineum Therapeutics shares owned by Cannon Global Investment Management

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Cannon Global Investment Management from 13F filings

Historical chart of Cannon Global Investment Management investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Cannon Global Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Cannon Global Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $170k 13k 13.06

More positions owned by Cannon Global Investment Management

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Norfolk Southern (NSC)
Terns Pharmaceuticals (TERN)
Sun Communities (SUI)
Madrigal Pharmaceuticals (MDGL)
Cheniere Energy Com New (LNG)
Qiagen Nv Ord Shares (QGEN)
Zoom Communications Cl A (ZM)
Cantor Equity Partners I Shs Cl A (CEPO)
Electronic Arts (EA)
Fox Corp Cl B Com (FOX)
Marvell Technology (MRVL)
Cantor Equity Partners Ii In Cl A Ord Shs (CEPT)
Renatus Tactical Acquis Shs Cl A (RTAC)
Ss&c Technologies Holding (SSNC)

View all positions for Cannon Global Investment Management

Top funds holding Contineum Therapeutics

Suvretta Capital Management
Henderson Group
Johnson & Johnson
Franklin Resources
Balyasny Asset Management
Millennium Management
Baker Bros. Advisors
RA Capital Management
Vanguard Group
Perceptive Advisors
Vanguard Capital Management
FMR
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Longaeva Partners

View all funds holding Contineum Therapeutics